Monopar Therapeutics Inc.
Market Cap
$402.76M
P/E Ratio
-15.22
EPS
$-3.96
Dividend Yield
0.00%
52-Week Range
$26.05 — $105.00
Volume
318.77K
Avg Volume
277.45K
Beta
1.67
P/E (TTM)
-15.22
Forward P/E
—
PEG Ratio
1.01
P/S (TTM)
0.00
P/B (TTM)
2.87
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.26%
ROA (TTM)
-0.13%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.00
Current Ratio
56.10
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.39%
EPS Growth (5Y)
-0.38%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-3.23
EPS Est (Next Year)
$-3.83
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$20.17
Price Target Range
Consensus Target: $108.38(79.8% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
-3621
Outstanding Shares
6.68M
Float
4.54M
Free Float %
68.01%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2019-12-19
Employees
14
CEO
Chandler D. Robinson
Index Membership
—
Website
https://www.monopartx.com
Monopar Therapeutics Inc. (MNPR) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $402.76M, a P/E ratio of -15.22, MNPR is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MNPR against other stocks using dozens of fundamental and technical filters.
Monopar Therapeutics Inc. (MNPR) has a trailing twelve-month (TTM) P/E ratio of -15.22. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Monopar Therapeutics Inc. (MNPR) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Monopar Therapeutics Inc. (MNPR) has a market capitalization of $402.76 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.